The results are shown in Figure 4A, revealing significant inhibition of GBC tumor growth in the nude mouse subcutaneous tumor model following ANLN silencing, as confirmed by the reduced weight and volume of the subcutaneous tumors (Figure 4B,C). The gene discussed is ANLN; the disease is neoplasm.